Cure8 research brief
Why This Matters
AI-assisted detection tools and disease-specific optical classifications could improve lesion detection and real-time characterization during UC surveillance, potentially affecting surveillance accuracy and biopsy/management decisions.
Who Should Pay Attention
Endoscopists and gastroenterologists performing UC surveillance; researchers in AI-assisted endoscopy; patients with ulcerative colitis interested in surveillance technology advances.
Study Snapshot
What To Know
The study enrolled patients with UC undergoing surveillance and compared white-light, linked-colour/blue-laser imaging, and LCI plus CAD-EYE in a fixed sequence.
CAD-EYE-assisted withdrawal observed complete lesion detection in this protocol, but because the exam order was fixed and withdrawal times were not prospectively recorded, the trial cannot isolate the independent added value of CAD-EYE.
Kudo-IBD (a disease-specific optical classification) showed higher diagnostic accuracy than Kudo, NICE, and other methods tested, with a notably high negative predictive value in this sample.
The authors call for larger studies using independent randomized or balanced examination sequences, prospectively recorded withdrawal times, and external validation of Kudo-IBD before routine adoption.
Keep In Mind
This is an abstract-level report of a single-center prospective tandem study with a fixed imaging sequence and no prospectively recorded withdrawal times; results need confirmation in larger, independently-sequenced and externally validated studies.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.